People: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

7.22USD
29 Jul 2014
Price Change (% chg)

$0.15 (+2.12%)
Prev Close
$7.07
Open
$7.08
Day's High
$7.46
Day's Low
$7.07
Volume
1,904,630
Avg. Vol
6,407,241
52-wk High
$8.61
52-wk Low
$2.26

Search Stocks

Fenton, Mary Kay 

Brief Biography

Ms. Mary Kay Fenton is Chief Financial Officer, Senior Vice President of Achillion Pharmaceuticals Inc. Prior to joining Achillion in October 2000, Ms. Fenton, a certified public accountant, held various positions within the Technology Industry Group at PricewaterhouseCoopers LLP, an independent registered public accounting firm, from 1991 to 2000, most recently as Senior Manager responsible for the life sciences practice in Connecticut. Prior to 1991, Ms. Fenton was an economic development associate in the nonprofit sector. Ms. Fenton is on the Executive Committee of the Board of Directors of Connecticut Business and Industry Association, a representative business organization. Ms. Fenton holds an M.B.A. in Finance from the Graduate School of Business at the University of Connecticut and an A.B. in Economics from the College of the Holy Cross.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
400,656 -- 588,960 989,616

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 10,625 110,500.00
Name Fiscal Year Total

David Scheer

--

Milind Deshpande

4,853,430

Mary Kay Fenton

989,616

Gautam Shah

883,243

David Apelian

2,175,130

Joseph Truitt

886,617
As Of 30 Dec 2013
Search Stocks